Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-7.96M.
ENTERPRISE VALUE (EV)
$-7.96M
Sunshine Biopharma, Inc.
Market Cap
$946332.00
Enterprise Value (EV)
$-7.96M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Sunshine Biopharma, Inc. (SBFM) | $946332.00 | $-7.96M |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | N/A |
| Bone Biologics Corporation (BBLG)vs › | $868077.00 | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $838843.00 | N/A |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $824550.00 | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.12M | $796474.00 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.13M | $2.17M |
Market Cap
$946332.00
Total Debt
$215637.00
Cash
$9.12M
Enterprise Value
$-7.96M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
